课题基金 / 基金详情

HYPERINSULIMEMIA AND ENDOTHELIN EXCRETION

HYPERINSULIMEMIA AND ENDOTHELIN EXCRETION
高胰岛素血症和内皮素排泄
批准号:
3779591
负责人:
H KLEIN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

H KLEIN的其他基金

相似基金

相关文献

中文摘要
翻译
抵抗胰岛素对葡萄糖代谢的作用,随之而来
英文摘要
Resistance to the action of Insulin on glucose metabolism, with ensuing compensatory hyperinsulinemia, is closely linked to essential hypertension. The decreased insulin sensitivity observed in hypertensive patients is present in both obese and non-obese subjects. Hyperinsulinemia has been found to increase sodium and water retention by the kidneys and to increase circulating levels of norepinephrine. It has also been shown to increase blood pressure by some authors, but not others. On the other hand, endothelin (ET), is a potent endogenous vasoconstrictor, produced by the endothelium. It is found in small amounts in plasma, compared to high levels in urine. Despite many studies in the literature on the subject, the roles played by ET and hyperinsulinemia in essential hypertension are still unclear. We are investigating: 1) the effects of hyperinsulinemia on blood pressure and on urinary excretion of endothelin (UETV) in normal volunteers and in salt sensitive and salt resistant hypertensive subjects. The euglycemic insulin clamp technique, developed by Dr. DeFronzo, is being used, to assess the degree of insulin resistance and provide a controlled hyperinsulinemic state.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ROLE OF ANGIOTENSIN II ON REGULATION OF ENDOTHELIN EXCRETION
HYPERINSULIMEMIA AND ENDOTHELIN EXCRETION
海外基金